The significant upregulation of CA12 in and on tumor-purified monocytes was further confirmed by immunoblotting and flow cytometry analysis, which also showed that all the other CD14– cellular components expressed none to very low levels of CA12 regardless of their tissue area of origin (Figure 1, D and E). This evidence concerns the gene CD14 and neoplasm.